Catalog No.:AA0033PY

6281-58-9 | 7-Chloro-4-(2-methylpyrrolidin-1-yl)quinoline

Name: Name:7-Chloro-4-(2-methylpyrrolidin-1-yl)quinoline
Brand: AABLOCKS
SKU: AA0033PY
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

5mg

>98%

3 weeks

$554.00 $388.00

- +

10mg

>98%

3 weeks

$947.00 $663.00

- +

25mg

>98%

3 weeks

$1,840.00 $1,288.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA0033PY

Chemical Name:

7-Chloro-4-(2-methylpyrrolidin-1-yl)quinoline

CAS Number:

6281-58-9

Molecular Formula:

C14H15ClN2

Molecular Weight:

246.7353

MDL Number:

MFCD01685619

SMILES:

Clc1ccc2c(c1)nccc2N1CCCC1C

NSC Number:

5820

Properties

Form:

Liquid

Storage:

2-8℃;

Computed Properties

Complexity:

271

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Rotatable Bond Count:

Undefined Atom Stereocenter Count:

XLogP3:

3.9

Downstream Synthesis Route

54-05-7

17341-93-4

6281-58-9

N,N-diethyl-2,2,2-trichloroethylcarbamate

7-chloro-4-(4'-N-ethyl-N-2,2,2-trichloroethoxycarbonylamino-1'-methylbutylamino)quinoline

[1]Synthesis,1995,p.147-149

54-05-7

17341-93-4

6281-58-9

7-chloro-4-(4'-N-ethyl-N-2,2,2-trichloroethoxycarbonylamino-1'-methylbutylamino)quinoline

[1]Synthesis,1995,p.147-149

Literature

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Manzo C, et al. Psychomotor Agitation Following Treatment with Hydroxychloroquine. Drug Saf Case Rep. 2017 Dec;4(1):6.

Title: Lamphier M, et al. Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo. Mol Pharmacol. 2014 Mar;85(3):429-40.

Title: Yao X, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Mar 9. pii: ciaa237.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country: